M EN2 (Eprosartan mesylate 400 mg)
Pill imprint M EN2 has been identified as Eprosartan mesylate 400 mg.
Eprosartan is used in the treatment of high blood pressure and belongs to the drug class angiotensin receptor blockers. There is positive evidence of human fetal risk during pregnancy. Eprosartan 400 mg is not a controlled substance under the Controlled Substance Act (CSA).
More about eprosartan
- Other brands: Teveten
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.